Loading…

Utility of immunohistochemistry in breast cancer practice

Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to...

Full description

Saved in:
Bibliographic Details
Published in:Breast cancer (Tokyo, Japan) Japan), 2004-11, Vol.11 (4), p.334-338
Main Authors: Umemura, Shinobu, Osamura, R Yoshiyuki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603
cites cdi_FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603
container_end_page 338
container_issue 4
container_start_page 334
container_title Breast cancer (Tokyo, Japan)
container_volume 11
creator Umemura, Shinobu
Osamura, R Yoshiyuki
description Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to provide predictive factors for efficient treatments. Technical developments make it possible to utilize IHC as a convenient diagnostic tool, and to use it in advanced protocols in combination with other histochemical techniques as well. In this review article, the development of IHC, IHC for differential diagnosis and IHC for providing information about hormone receptors and HER2 in breast cancer practice will be introduced. Standardization and quality control are critical issues to utilize IHC adequately in breast cancer practice.
doi_str_mv 10.1007/BF02968039
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67189500</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67189500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603</originalsourceid><addsrcrecordid>eNpFkM1Kw0AYRQdRbK1ufADJyoUQ_eZ_stRiVSi4seswmXxDI_mpM5NF396UFrq6d3G4XA4h9xSeKYB-eVsBK5QBXlyQOTUGcsE4v5w6F5Aro8yM3MT4CyC4BnVNZlQqEIXRc1JsUtM2aZ8NPmu6buyHbRPT4LbYTRn2WdNnVUAbU-Zs7zBku2Bdahzekitv24h3p1yQzer9Z_mZr78_vpav69wxyVOulahqVde6MoLXDr2laDVDpgtvhPIWqJJUMKydEVoIVVnBpWRGSu8qBXxBHo-7uzD8jRhTOT1z2La2x2GMpdLUFBIO4NMRdGGIMaAvd6HpbNiXFMqDqPIsaoIfTqtj1WF9Rk9m-D82HmKG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67189500</pqid></control><display><type>article</type><title>Utility of immunohistochemistry in breast cancer practice</title><source>Springer Nature</source><creator>Umemura, Shinobu ; Osamura, R Yoshiyuki</creator><creatorcontrib>Umemura, Shinobu ; Osamura, R Yoshiyuki</creatorcontrib><description>Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to provide predictive factors for efficient treatments. Technical developments make it possible to utilize IHC as a convenient diagnostic tool, and to use it in advanced protocols in combination with other histochemical techniques as well. In this review article, the development of IHC, IHC for differential diagnosis and IHC for providing information about hormone receptors and HER2 in breast cancer practice will be introduced. Standardization and quality control are critical issues to utilize IHC adequately in breast cancer practice.</description><identifier>ISSN: 1340-6868</identifier><identifier>EISSN: 1880-4233</identifier><identifier>DOI: 10.1007/BF02968039</identifier><identifier>PMID: 15604987</identifier><language>eng</language><publisher>Japan</publisher><subject>Breast Neoplasms - diagnosis ; Breast Neoplasms - metabolism ; Female ; Humans ; Immunohistochemistry - methods ; Immunohistochemistry - standards ; Neoplasms, Hormone-Dependent - diagnosis ; Neoplasms, Hormone-Dependent - metabolism ; Predictive Value of Tests ; Receptor, ErbB-2 - metabolism</subject><ispartof>Breast cancer (Tokyo, Japan), 2004-11, Vol.11 (4), p.334-338</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603</citedby><cites>FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15604987$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Umemura, Shinobu</creatorcontrib><creatorcontrib>Osamura, R Yoshiyuki</creatorcontrib><title>Utility of immunohistochemistry in breast cancer practice</title><title>Breast cancer (Tokyo, Japan)</title><addtitle>Breast Cancer</addtitle><description>Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to provide predictive factors for efficient treatments. Technical developments make it possible to utilize IHC as a convenient diagnostic tool, and to use it in advanced protocols in combination with other histochemical techniques as well. In this review article, the development of IHC, IHC for differential diagnosis and IHC for providing information about hormone receptors and HER2 in breast cancer practice will be introduced. Standardization and quality control are critical issues to utilize IHC adequately in breast cancer practice.</description><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry - methods</subject><subject>Immunohistochemistry - standards</subject><subject>Neoplasms, Hormone-Dependent - diagnosis</subject><subject>Neoplasms, Hormone-Dependent - metabolism</subject><subject>Predictive Value of Tests</subject><subject>Receptor, ErbB-2 - metabolism</subject><issn>1340-6868</issn><issn>1880-4233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpFkM1Kw0AYRQdRbK1ufADJyoUQ_eZ_stRiVSi4seswmXxDI_mpM5NF396UFrq6d3G4XA4h9xSeKYB-eVsBK5QBXlyQOTUGcsE4v5w6F5Aro8yM3MT4CyC4BnVNZlQqEIXRc1JsUtM2aZ8NPmu6buyHbRPT4LbYTRn2WdNnVUAbU-Zs7zBku2Bdahzekitv24h3p1yQzer9Z_mZr78_vpav69wxyVOulahqVde6MoLXDr2laDVDpgtvhPIWqJJUMKydEVoIVVnBpWRGSu8qBXxBHo-7uzD8jRhTOT1z2La2x2GMpdLUFBIO4NMRdGGIMaAvd6HpbNiXFMqDqPIsaoIfTqtj1WF9Rk9m-D82HmKG</recordid><startdate>20041124</startdate><enddate>20041124</enddate><creator>Umemura, Shinobu</creator><creator>Osamura, R Yoshiyuki</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041124</creationdate><title>Utility of immunohistochemistry in breast cancer practice</title><author>Umemura, Shinobu ; Osamura, R Yoshiyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry - methods</topic><topic>Immunohistochemistry - standards</topic><topic>Neoplasms, Hormone-Dependent - diagnosis</topic><topic>Neoplasms, Hormone-Dependent - metabolism</topic><topic>Predictive Value of Tests</topic><topic>Receptor, ErbB-2 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Umemura, Shinobu</creatorcontrib><creatorcontrib>Osamura, R Yoshiyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Umemura, Shinobu</au><au>Osamura, R Yoshiyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utility of immunohistochemistry in breast cancer practice</atitle><jtitle>Breast cancer (Tokyo, Japan)</jtitle><addtitle>Breast Cancer</addtitle><date>2004-11-24</date><risdate>2004</risdate><volume>11</volume><issue>4</issue><spage>334</spage><epage>338</epage><pages>334-338</pages><issn>1340-6868</issn><eissn>1880-4233</eissn><abstract>Immunohistochemistry (IHC) has been used to search for specific protein-products, to observe the unique characteristics of breast cancer, to differentiate breast cancer from cancers of other sites origin, to obtain information regarding genetic alterations, to investigate prognostic factors, and to provide predictive factors for efficient treatments. Technical developments make it possible to utilize IHC as a convenient diagnostic tool, and to use it in advanced protocols in combination with other histochemical techniques as well. In this review article, the development of IHC, IHC for differential diagnosis and IHC for providing information about hormone receptors and HER2 in breast cancer practice will be introduced. Standardization and quality control are critical issues to utilize IHC adequately in breast cancer practice.</abstract><cop>Japan</cop><pmid>15604987</pmid><doi>10.1007/BF02968039</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1340-6868
ispartof Breast cancer (Tokyo, Japan), 2004-11, Vol.11 (4), p.334-338
issn 1340-6868
1880-4233
language eng
recordid cdi_proquest_miscellaneous_67189500
source Springer Nature
subjects Breast Neoplasms - diagnosis
Breast Neoplasms - metabolism
Female
Humans
Immunohistochemistry - methods
Immunohistochemistry - standards
Neoplasms, Hormone-Dependent - diagnosis
Neoplasms, Hormone-Dependent - metabolism
Predictive Value of Tests
Receptor, ErbB-2 - metabolism
title Utility of immunohistochemistry in breast cancer practice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T21%3A24%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utility%20of%20immunohistochemistry%20in%20breast%20cancer%20practice&rft.jtitle=Breast%20cancer%20(Tokyo,%20Japan)&rft.au=Umemura,%20Shinobu&rft.date=2004-11-24&rft.volume=11&rft.issue=4&rft.spage=334&rft.epage=338&rft.pages=334-338&rft.issn=1340-6868&rft.eissn=1880-4233&rft_id=info:doi/10.1007/BF02968039&rft_dat=%3Cproquest_cross%3E67189500%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c253t-764bd6dd7b843dcefa1ea72e279f846fa0165142edc847446ba43552855fcb603%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67189500&rft_id=info:pmid/15604987&rfr_iscdi=true